All In Biotech

Drug Trial Radar · NCT04518995

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (THRIVE-AA1)

Last checked: Nov 19, 2026Latest source record: May 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 706 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

706

Actual

Start

Nov 23, 2020

Primary completion

Apr 19, 2022

Study completion Apr 19, 2022

Sponsor

Lead sponsor
Concert PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 19, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss.

Conditions

  • Alopecia Areata

Interventions

  • CTP-543 matching placeboDrug

    Administered as tablets.

  • CTP-543Drug

    Administered as tablets.

  • CTP-543Drug

    Administered as tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving an Absolute Severity of Alopecia Tool (SALT) Score of ≤20 at Week 24Time frame: Week 24

Locations

72 sites in 5 countries. Site status is shown where the registry gives one.

  • Total Skin and Beauty Dermatology Center

    Birmingham, Alabama

  • Kern Research, Inc.

    Bakersfield, California

  • California Dermatology & Clinical Research Institute

    Encinitas, California

  • UC Irvine Dermatology Clinical Research Center

    Irvine, California

  • Quest Dermatology Research

    Northridge, California

  • Kaiser Permanente

    Oakland, California

  • Kaiser Permanente South Sacramento

    Sacramento, California

  • Kaiser Permanente

    San Francisco, California

  • Colorado Center for Dermatology and Skin Surgery

    Centennial, Colorado

  • Colorado Medical Research Center

    Denver, Colorado

  • Yale University, Church Street Research Unit

    New Haven, Connecticut

  • Lenus Research & Medical Group, LLC

    Sweetwater, Florida

  • Clinical Research Trials of Florida, Inc.

    Tampa, Florida

  • Forward Clinical Trials Inc.

    Tampa, Florida

  • Denova Research

    Chicago, Illinois

  • Northwestern Memorial Hospital, Department of Dermatology

    Chicago, Illinois

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana

  • DS Research

    New Albany, Indiana

  • The Indiana Clinical Trials Center, PC

    Plainfield, Indiana

  • DS Research

    Louisville, Kentucky

  • Qualmedica Research LLC

    Owensboro, Kentucky

  • Massachusetts General Hospital - Clinic

    Boston, Massachusetts

  • Brigham and Women's Hospital

    Boston, Massachusetts

  • Clarkston Skin Research

    Clarkston, Michigan

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • University of Minnesota Department of Dermatology

    Minneapolis, Minnesota

  • Skin Laser and Surgery Specialists of NJ

    Hackensack, New Jersey

  • Sadick Research Group

    New York, New York

  • Darst Dermatology

    Charlotte, North Carolina

  • Dermatology Specialists of Charlotte

    Charlotte, North Carolina

  • Wake Forest University Health Sciences, Department of Dermatology

    Winston-Salem, North Carolina

  • Bexley Dermatology Research

    Bexley, Ohio

  • Vital Prospects Clinical Research Institute, P.C.

    Tulsa, Oklahoma

  • Northwest Dermatology Institute

    Portland, Oregon

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Dermatology Associates Of Plymouth Meeting

    Plymouth Meeting, Pennsylvania

  • PEAK Research

    Upper Saint Clair, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • Clinical Research Center of the Carolinas

    Charleston, South Carolina

  • Palmetto Clinical Trial Services

    Fountain Inn, South Carolina

Showing 40 of 72 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.